Cargando…

Preliminary results in the analysis of the immune response after aneurysmal subarachnoid hemorrhage

Cerebral vasospasm (VSP) is a common phenomenon after aneurysmal subarachnoid hemorrhage (aSAH) and contributes to neurocognitive decline. The natural history of the pro-inflammatory immune response after aSAH has not been prospectively studied in human cerebrospinal fluid (CSF). In this pilot study...

Descripción completa

Detalles Bibliográficos
Autores principales: Roa, Jorge A., Sarkar, Deepon, Zanaty, Mario, Ishii, Daizo, Lu, Yongjun, Karandikar, Nitin J., Hasan, David M., Ortega, Sterling B., Samaniego, Edgar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367262/
https://www.ncbi.nlm.nih.gov/pubmed/32678268
http://dx.doi.org/10.1038/s41598-020-68861-y
_version_ 1783560388319641600
author Roa, Jorge A.
Sarkar, Deepon
Zanaty, Mario
Ishii, Daizo
Lu, Yongjun
Karandikar, Nitin J.
Hasan, David M.
Ortega, Sterling B.
Samaniego, Edgar A.
author_facet Roa, Jorge A.
Sarkar, Deepon
Zanaty, Mario
Ishii, Daizo
Lu, Yongjun
Karandikar, Nitin J.
Hasan, David M.
Ortega, Sterling B.
Samaniego, Edgar A.
author_sort Roa, Jorge A.
collection PubMed
description Cerebral vasospasm (VSP) is a common phenomenon after aneurysmal subarachnoid hemorrhage (aSAH) and contributes to neurocognitive decline. The natural history of the pro-inflammatory immune response after aSAH has not been prospectively studied in human cerebrospinal fluid (CSF). In this pilot study, we aimed to identify specific immune mediators of VSP after aSAH. Peripheral blood (PB) and CSF samples from patients with aSAH were prospectively collected at different time-points after hemorrhage: days 0–1 (acute); days 2–4 (pre-VSP); days 5–9 (VSP) and days 10 + (post-VSP peak). Presence and severity of VSP was assessed with computed tomography angiography/perfusion imaging and clinical examination. Cytokine and immune mediators’ levels were quantified using ELISA. Innate and adaptive immune cells were characterized by flow cytometry, and cell counts at different time-points were compared with ANOVA. Confocal immunostaining was used to determine the presence of specific immune cell populations detected in flow cytometry. Thirteen patients/aneurysms were included. Five (38.5%) patients developed VSP after a mean of 6.8 days from hemorrhage. Flow cytometry demonstrated decreased numbers of CD45+ cells during the acute phase in PB of aSAH patients compared with healthy controls. In CSF of VSP patients, NK cells (CD3-CD161 +) were increased during the acute phase and progressively declined, whereas CD8+CD161+ lymphocytes significantly increased at days 5–9. Microglia cells (CD45dimCD11b +) increased over time after SAH. This increase was particularly significant in patients with VSP. Levels of VEGF and MMP-9 were consistently higher in VSP patients, with the highest difference occurring at the acute phase. Confocal immunostaining demonstrated the presence of CD8+CD161+ lymphocytes in the arterial wall of two unruptured intracranial aneurysms. In this preliminary study, human CSF showed active presence of innate and adaptive immune cells after aSAH. CD8+CD161+ lymphocytes may have an important role in the inflammatory response after aneurysmal rupture and were identified in the aneurysmal wall of unruptured brain aneurysms. Microglia activation occurs 6 + days after aSAH.
format Online
Article
Text
id pubmed-7367262
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-73672622020-07-20 Preliminary results in the analysis of the immune response after aneurysmal subarachnoid hemorrhage Roa, Jorge A. Sarkar, Deepon Zanaty, Mario Ishii, Daizo Lu, Yongjun Karandikar, Nitin J. Hasan, David M. Ortega, Sterling B. Samaniego, Edgar A. Sci Rep Article Cerebral vasospasm (VSP) is a common phenomenon after aneurysmal subarachnoid hemorrhage (aSAH) and contributes to neurocognitive decline. The natural history of the pro-inflammatory immune response after aSAH has not been prospectively studied in human cerebrospinal fluid (CSF). In this pilot study, we aimed to identify specific immune mediators of VSP after aSAH. Peripheral blood (PB) and CSF samples from patients with aSAH were prospectively collected at different time-points after hemorrhage: days 0–1 (acute); days 2–4 (pre-VSP); days 5–9 (VSP) and days 10 + (post-VSP peak). Presence and severity of VSP was assessed with computed tomography angiography/perfusion imaging and clinical examination. Cytokine and immune mediators’ levels were quantified using ELISA. Innate and adaptive immune cells were characterized by flow cytometry, and cell counts at different time-points were compared with ANOVA. Confocal immunostaining was used to determine the presence of specific immune cell populations detected in flow cytometry. Thirteen patients/aneurysms were included. Five (38.5%) patients developed VSP after a mean of 6.8 days from hemorrhage. Flow cytometry demonstrated decreased numbers of CD45+ cells during the acute phase in PB of aSAH patients compared with healthy controls. In CSF of VSP patients, NK cells (CD3-CD161 +) were increased during the acute phase and progressively declined, whereas CD8+CD161+ lymphocytes significantly increased at days 5–9. Microglia cells (CD45dimCD11b +) increased over time after SAH. This increase was particularly significant in patients with VSP. Levels of VEGF and MMP-9 were consistently higher in VSP patients, with the highest difference occurring at the acute phase. Confocal immunostaining demonstrated the presence of CD8+CD161+ lymphocytes in the arterial wall of two unruptured intracranial aneurysms. In this preliminary study, human CSF showed active presence of innate and adaptive immune cells after aSAH. CD8+CD161+ lymphocytes may have an important role in the inflammatory response after aneurysmal rupture and were identified in the aneurysmal wall of unruptured brain aneurysms. Microglia activation occurs 6 + days after aSAH. Nature Publishing Group UK 2020-07-16 /pmc/articles/PMC7367262/ /pubmed/32678268 http://dx.doi.org/10.1038/s41598-020-68861-y Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Roa, Jorge A.
Sarkar, Deepon
Zanaty, Mario
Ishii, Daizo
Lu, Yongjun
Karandikar, Nitin J.
Hasan, David M.
Ortega, Sterling B.
Samaniego, Edgar A.
Preliminary results in the analysis of the immune response after aneurysmal subarachnoid hemorrhage
title Preliminary results in the analysis of the immune response after aneurysmal subarachnoid hemorrhage
title_full Preliminary results in the analysis of the immune response after aneurysmal subarachnoid hemorrhage
title_fullStr Preliminary results in the analysis of the immune response after aneurysmal subarachnoid hemorrhage
title_full_unstemmed Preliminary results in the analysis of the immune response after aneurysmal subarachnoid hemorrhage
title_short Preliminary results in the analysis of the immune response after aneurysmal subarachnoid hemorrhage
title_sort preliminary results in the analysis of the immune response after aneurysmal subarachnoid hemorrhage
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367262/
https://www.ncbi.nlm.nih.gov/pubmed/32678268
http://dx.doi.org/10.1038/s41598-020-68861-y
work_keys_str_mv AT roajorgea preliminaryresultsintheanalysisoftheimmuneresponseafteraneurysmalsubarachnoidhemorrhage
AT sarkardeepon preliminaryresultsintheanalysisoftheimmuneresponseafteraneurysmalsubarachnoidhemorrhage
AT zanatymario preliminaryresultsintheanalysisoftheimmuneresponseafteraneurysmalsubarachnoidhemorrhage
AT ishiidaizo preliminaryresultsintheanalysisoftheimmuneresponseafteraneurysmalsubarachnoidhemorrhage
AT luyongjun preliminaryresultsintheanalysisoftheimmuneresponseafteraneurysmalsubarachnoidhemorrhage
AT karandikarnitinj preliminaryresultsintheanalysisoftheimmuneresponseafteraneurysmalsubarachnoidhemorrhage
AT hasandavidm preliminaryresultsintheanalysisoftheimmuneresponseafteraneurysmalsubarachnoidhemorrhage
AT ortegasterlingb preliminaryresultsintheanalysisoftheimmuneresponseafteraneurysmalsubarachnoidhemorrhage
AT samaniegoedgara preliminaryresultsintheanalysisoftheimmuneresponseafteraneurysmalsubarachnoidhemorrhage